Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Luther

Showing results (11-20 of 27) with videos related to

Pageof 3
Sort By:
Molecular Medicine (Cambridge, Mass.)|December 15, 2021
Rab31-dependent regulation of transforming growth factor ß expression in breast cancer cellsSusanne Soelch, Nathalie Beaufort, Daniela Loessner, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 23, 2003
Proteolytic regulation of the urokinase receptor/CD87 on monocytic cells by neutrophil elastase and cathepsin GNathalie Beaufort, Dominique Leduc, Jean-Claude Rousselle, et al.
Research and Practice in Thrombosis and Haemostasis|June 19, 2023
Detection of tissue factor-positive extracellular vesicles using the ExoView R100 systemJoshua M J Price, Yohei Hisada, Jon Hazeldine, et al.
Breast Cancer Research and Treatment|July 17, 2010
Overexpression of the urokinase receptor mRNA splice variant uPAR-del4/5 affects tumor-associated processes of breast cancer cells in vitro and in vivoSumito Sato, Charlotte Kopitz, Bettina Grismayer, et al.
Histopathology|September 16, 2010
Prognostic relevance of tumour cell-associated uPAR expression in invasive ductal breast carcinomaMatthias Kotzsch, Katharina Bernt, Katrin Friedrich, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|January 7, 2003
Intravascular tissue factor initiates coagulation via circulating microvesicles and plateletsIngrid Müller, Antje Klocke, Meike Alex, et al.
Biological Chemistry|May 14, 2013
Overexpression of the urokinase receptor splice variant uPAR-del4/5 in breast cancer cells affects cell adhesion and invasion in a dose-dependent manner and modulates transcription of tumor-associated genesBettina Grismayer, Sumito Sato, Charlotte Kopitz, et al.
Molecular Cancer|August 28, 2012
Rab31 expression levels modulate tumor-relevant characteristics of breast cancer cellsBettina Grismayer, Susanne Sölch, Bastian Seubert, et al.
International Journal of Molecular Medicine|January 22, 2008
Quantitative RT-PCR assays for the determination of urokinase-type plasminogen activator and plasminogen activator inhibitor type 1 mRNA in primary tumor tissue of breast cancer patients: comparison to antigen quantification by ELISAJulia C Biermann, Leon Holzscheiter, Matthias Kotzsch, et al.
BMC Cancer|June 28, 2011
Combined mRNA expression levels of members of the urokinase plasminogen activator (uPA) system correlate with disease-associated survival of soft-tissue sarcoma patientsMatthias Kotzsch, Viktor Magdolen, Thomas Greither, et al.
Pageof 3

Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
Molecular Medicine (Cambridge, Mass.)|December 15, 2021
Rab31-dependent regulation of transforming growth factor ß expression in breast cancer cellsSusanne Soelch, Nathalie Beaufort, Daniela Loessner, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 23, 2003
Proteolytic regulation of the urokinase receptor/CD87 on monocytic cells by neutrophil elastase and cathepsin GNathalie Beaufort, Dominique Leduc, Jean-Claude Rousselle, et al.
Research and Practice in Thrombosis and Haemostasis|June 19, 2023
Detection of tissue factor-positive extracellular vesicles using the ExoView R100 systemJoshua M J Price, Yohei Hisada, Jon Hazeldine, et al.
Breast Cancer Research and Treatment|July 17, 2010
Overexpression of the urokinase receptor mRNA splice variant uPAR-del4/5 affects tumor-associated processes of breast cancer cells in vitro and in vivoSumito Sato, Charlotte Kopitz, Bettina Grismayer, et al.
Histopathology|September 16, 2010
Prognostic relevance of tumour cell-associated uPAR expression in invasive ductal breast carcinomaMatthias Kotzsch, Katharina Bernt, Katrin Friedrich, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|January 7, 2003
Intravascular tissue factor initiates coagulation via circulating microvesicles and plateletsIngrid Müller, Antje Klocke, Meike Alex, et al.
Biological Chemistry|May 14, 2013
Overexpression of the urokinase receptor splice variant uPAR-del4/5 in breast cancer cells affects cell adhesion and invasion in a dose-dependent manner and modulates transcription of tumor-associated genesBettina Grismayer, Sumito Sato, Charlotte Kopitz, et al.
Molecular Cancer|August 28, 2012
Rab31 expression levels modulate tumor-relevant characteristics of breast cancer cellsBettina Grismayer, Susanne Sölch, Bastian Seubert, et al.
International Journal of Molecular Medicine|January 22, 2008
Quantitative RT-PCR assays for the determination of urokinase-type plasminogen activator and plasminogen activator inhibitor type 1 mRNA in primary tumor tissue of breast cancer patients: comparison to antigen quantification by ELISAJulia C Biermann, Leon Holzscheiter, Matthias Kotzsch, et al.
BMC Cancer|June 28, 2011
Combined mRNA expression levels of members of the urokinase plasminogen activator (uPA) system correlate with disease-associated survival of soft-tissue sarcoma patientsMatthias Kotzsch, Viktor Magdolen, Thomas Greither, et al.
Pageof 3